MedTrace Logo

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

NCT06220266 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-05-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to answer are:

• phytoestrogen from Pueraria Mirifica can reduce serum triglyceride, total cholesterol, LDL and increase HDL or not

Participants will receive capsules which composed of dry weight 50 mg of Pueraria Mirifica twice a day for 2 months. Researchers will compare with diet control\&life style modification to see if there is the improvement of serum lipid parameters

Conditions

  • Dyslipidemias
  • Hypertriglyceridemia
  • Hypercholesterolemia
  • Hyper-LDL-cholesterolemia
  • Hypo HDL Cholesterolaemia
  • Postmenopausal Symptoms

Interventions

DRUG

Phytoestrogen

consume 1 capsule twice a day for 2 months which one capsule composed of dry weight 50 mg of Pueraria Mirifica 1or Pueraria Mirifica 2 or Pueraria Mirifica 3

DRUG

Diet control & life style modification

Diet control \& life style modification

Sponsors & Collaborators

  • Dhurakij Pundit University

    lead OTHER

Principal Investigators

  • Prischa Saengow, MD. · Dhurakij Pundit University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-02
Primary Completion
2024-08-31
Completion
2024-11-30

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06220266 on ClinicalTrials.gov